Jeffrey W. Jacobs - Nov 22, 2021 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role
Chief Scientific Officer
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for Jeffrey W. Jacobs
Stock symbol
ARDX
Transactions as of
Nov 22, 2021
Transactions value $
-$5,629
Form type
4
Date filed
11/24/2021, 03:06 PM
Previous filing
Nov 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARDX Common Stock Sale -$4.88K -5K -3.99% $0.98* 120K Nov 22, 2021 Direct F1, F2
transaction ARDX Common Stock Sale -$748 -754 -0.63% $0.99 119K Nov 22, 2021 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2021.
F2 This transaction was executed in multiple trades in prices ranging from $0.96 to $0.992, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.